Pipeline

Medisyn is committed to creating superior products for important medical needs. Using our platform technology, we have rapidly advanced a broad portfolio of preclinical candidates that target major therapeutic categories including cancer, infectious disease, pain, sexual health and inflammation.



Key programs in Medisyn's Pipeline:

Pharmaceutical
Oncology
Non-small Cell Lung Cancer
   PKC Inhibition
   RAS Pathway
 
Pancreatic Cancer
   RAS Pathway
 
Malignant Melanoma
   RTKI
 
   
Infectious Disease
HIV/AIDS
   Protease Inhibition 
 
MRSA
 
Tuberculosis
 
   
Neuropathic Pain
   GABA-mimetics
MD Biosciences
   GABA Receptor Agonists
MD Biosciences
   
Alzheimer's Disease
   Selective Aβ1-40 and Aβ1-42 
  lowering agents
MSSM      
   Anti-aggregation agents
MSSM      
   
Inflammation
   Non-steroidal Anti-inflammatory
 
   
Nutraceutical
Acute Radiation Syndrome (ARS)
Radioprotectants
Humanetics   
Radiotherapeutics
Humanetics   
   
Satiety
   Serotonin inhibition
 
   Dopamine Inhibition
 
   Norepinephrine
 
   
Sexual Health
   Erectile Dysfunction
 
   Inhibited Sexual Disorder
 
   Premature Ejaculation
 
   



 
     
 
 
 
 
© 2012 Medisyn Technologies, Inc. Privacy and Terms of Use | 952-475-8084 | Contact Us